#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4668	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2732	419.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	2029	2029	T	579	T,C,A	547,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4668	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2732	419.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1763	1763	C	672	C	641	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8566	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4125	515.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1941	1941	A	667	A,C,G,T	641,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8566	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4125	515.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2575	2575	C	593	C,G	560,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8566	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4125	515.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2649	2649	A	556	A,T	534,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8566	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4125	515.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3201	3201	C	559	C,T,A	531,2,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	R7Q	NONSYN	19	21	CGG	605	607	CAG	111;111;109	C;A,G;G,T	108;106,3;105,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	D29N	NONSYN	85	87	GAT	671	673	AAT	90;90;90	A,G;A;T	81,2;85;86	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	P68L	NONSYN	202	204	CCG	788	790	TTG	85;85;85	T,C;T,C;G	79,2;79,3;82	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	F72Y	NONSYN	214	216	TTC	800	802	TAT	83;84;84	T;A,T;T,C	81;80,3;80,3	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	P74S	NONSYN	220	222	CCG	806	808	TCG	80;79;79	T,C;C,G;G,A	73,2;73,1;77,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	P75del	DEL	223	223	C	809	809	C	80	C	79	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	E76D	NONSYN	226	228	GAA	810	812	CTG	80;80;80	C,A;T,C,G;G	78,1;75,2,1;78	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	A90V	NONSYN	268	270	GCG	851	853	GTG	77;78;78	G;T,C;G	77;74,2;78	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	A91V	NONSYN	271	273	GCG	854	856	GTT	78;78;78	G;T;T,G	77;77;76,2	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	V97I	NONSYN	289	291	GTC	872	874	ATC	94;94;94	A,G;T,C;C	88,3;91,1;91	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	R136C	NONSYN	406	408	CGC	989	991	TGT	94;94;93	T,C;G,T;T,C,G	89,2;89,1;83,2,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	R148Q	NONSYN	442	444	CGG	1025	1027	CAG	92;91;92	C;A,G;G	87;85,2;86	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	T153N	NONSYN	457	459	ACC	1040	1042	AAC	90;90;89	A,G;A,C,G;C,A	87,1;84,2,2;86,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	D156I	NONSYN	466	468	GAC	1049	1051	ATT	92;92;92	A,G;T,A,G;T,C,A	87,2;86,2,1;87,2,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	T173A	NONSYN	517	519	ACA	1100	1102	GCG	89;88;88	G,A;C;G,A,C	85,1;86;83,1,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	E176A	NONSYN	526	528	GAA	1109	1111	GCG	87;86;86	G;C,A;G,A	86;84,1;83,2	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	T177E	NONSYN	529	531	ACC	1112	1114	GAA	85;85;85	G,A;A,C;A,C	83,1;79,1;82,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	V179I	NONSYN	535	537	GTC	1118	1120	ATC	79;79;77	A,G;T,G;C,A	74,2;77,1;75,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	T189I	NONSYN	565	567	ACG	1148	1150	ATA	71;71;70	A;T,C,A;A,G	70;68,1,1;67,2	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	539	424	folP	855	855	91.19	folP.l6.c4.ctg.1	2057	50.8	0	.	p	.	0	D191fs	FSHIFT	571	571	G	1154	1154	G	66	G	65	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1226	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	4155	73.0	1	SNP	p	S91F	1	.	.	271	273	TTC	792	794	TTC	92;92;92	T,G;T,A;C,T,A	83,1;86,1;86,1,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1226	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	4155	73.0	1	SNP	p	G95N	0	.	.	283	285	GGC	804	806	GGC	104;105;105	G;G;C	97;100;96	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1226	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	4155	73.0	1	SNP	p	D95G	1	.	.	283	285	GGC	804	806	GGC	104;105;105	G;G;C	97;100;96	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	496	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	2033	60.8	1	SNP	p	G45D	0	.	.	133	135	GGC	825	827	GGC	116;117;117	G;G;C	106;107;111	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	340	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1535	55.1	0	.	n	.	0	A197.	DEL	197	197	A	863	863	A	105	A	102	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	962	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3400	70.3	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1700	1702	GTC	97;96;96	G;T,C;C	92;91,1;93	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	962	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3400	70.3	1	SNP	p	D86N	0	.	.	256	258	GAC	806	808	GAC	63;63;70	G,C;A,G;C,T	54,1;49,1;65,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	962	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3400	70.3	1	SNP	p	R87W	0	.	.	259	261	CGT	809	811	CGT	72;72;72	C;G,C;T,A,G	64;58,1;62,1,1	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	962	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3400	70.3	1	SNP	p	R87I	0	.	.	259	261	CGT	809	811	CGT	72;72;72	C;G,C;T,A,G	64;58,1;62,1,1	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	962	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3400	70.3	1	SNP	p	S87R	1	.	.	259	261	CGT	809	811	CGT	72;72;72	C;G,C;T,A,G	64;58,1;62,1,1	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	962	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3400	70.3	1	SNP	p	S88P	0	.	.	262	264	TCC	812	814	TCC	72;71;70	T;C;C	66;63;67	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	980	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3341	72.7	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1682	1684	TGC	110;110;110	T,C;G,T;C	104,1;104,1;106	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	980	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3341	72.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1892	1894	GGC	87;87;87	G;G;C	76;73;76	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	886	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2821	74.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1416	1418	GCA	110;110;111	G;C;A	99;101;102	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	886	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2821	74.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1419	1421	ATC	112;112;111	A;T;C	102;106;105	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	886	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2821	74.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1431	1433	GTG	112;113;113	G,A;T;G	103,1;104;105	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	886	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2821	74.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1431	1433	GTG	112;113;113	G,A;T;G	103,1;104;105	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	886	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2821	74.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1935	1937	ACC	58;58;58	A;C,A;C,G	52;54,1;56,1	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	886	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2821	74.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1989	1991	GCG	57;57;57	G;C,G;G	47;44,1;45	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	886	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2821	74.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1989	1991	GCG	57;57;57	G;C,G;G	47;44,1;45	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	886	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2821	74.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2112	2114	GGC	76;77;77	G,C;G,A;C,T	73,1;74,1;73,3	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	886	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2821	74.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2121	2123	GGC	73;73;73	G,C;G;C	68,1;63;62	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	886	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2821	74.9	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2139	2141	TCG	80;80;80	T,G;C;G	63,1;68;71	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1212	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3716	80.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1949	1951	CCG	116;116;116	C,G;C,G;G,C,T	102,3;110,2;84,4,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	522	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2405	53.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	827	827	C	45	C	42	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	748	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2245	82.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	744	746	GAA	129;129;129	G;A;A	126;126;126	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	748	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2245	82.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	1032	1034	GAT	106;115;116	G;A;T,G	99;108;108,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	748	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2245	82.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1155	1157	TCA	118;119;119	T;C;A	115;113;117	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	748	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2245	82.0	0	.	p	.	0	I209T	NONSYN	625	627	ATC	1257	1259	ACC	111;111;108	A;C,T;C,G	107;107,1;103,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	748	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2245	82.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1284	1286	GTC	107;110;109	G;T;C,T	98;103;104,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	748	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2245	82.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1614	1616	GCA	118;118;117	G;C,A;A	115;112,3;114	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	748	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2245	82.0	1	SNP	p	G120K	1	.	.	358	360	AAG	990	992	AAG	111;110;108	A;A;G	105;103;103	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	748	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2245	82.0	1	SNP	p	A121D	1	.	.	361	363	GAC	993	995	GAC	108;108;107	G;A;C	102;102;101	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	748	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2245	82.0	1	SNP	p	D121N	0	.	.	361	363	GAC	993	995	GAC	108;108;107	G;A;C	102;102;101	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2514	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5421	115.6	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2243	2245	AAT	134;134;135	A,C;A;T	131,1;130;133	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	434	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1464	73.7	1	SNP	p	V57M	1	.	.	169	171	ATG	728	730	ATG	147;147;147	A;T;G	143;144;144	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	M177T	NONSYN	529	531	ATG	1121	1123	ACG	31;31;31	A;C;G	30;30;30	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	1142	1144	GAC	30;30;30	G;A;C	30;30;30	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	T190M	NONSYN	568	570	ACG	1160	1162	ATG	34;34;33	A;T,G;G	34;31,1;32	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1172	1174	TCA	33;33;33	T;C;A	33;33;33	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1328	1330	CCG	18;18;18	C;C,A;G	17;15,1;17	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	K252N	NONSYN	754	756	AAA	1346	1348	AAT	17;17;17	A;A;T	16;16;16	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	S259T	NONSYN	775	777	TCG	1367	1369	ACA	17;17;17	A;C;A	16;16;16	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	E260K	NONSYN	778	780	GAA	1370	1372	AAA	17;17;17	A;A;A	16;16;16	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1430	1432	TCG	12;12;12	T;C;G	10;11;11	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	I283V	NONSYN	847	849	ATA	1439	1441	GTA	12;12;12	G;T;A	11;11;11	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	I291V	NONSYN	871	873	ATT	1463	1465	GTT	10;10;9	G;T;T	9;9;8	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	K307R	NONSYN	919	921	AAG	1511	1513	AGA	5;5;6	A;G;A	5;5;6	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1601	1603	AAA	8;8;8	A;A;A	8;8;8	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1604	1606	AAG	8;8;8	A;A;G	8;8;8	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1619	1621	CAC	8;8;8	C,A;A;C	7,1;8;8	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1658	1660	GAA	7;7;7	G;A;A	7;7;7	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1736	1738	ACG	10;10;10	A;C;G	10;10;10	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1787	1789	ATT	13;13;13	A;T,G;T	13;12,1;13	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1790	1792	AGT	13;13;13	A;G;T	13;13;13	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1829	1831	CTA	15;15;15	C;T;A	15;15;15	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1871	1873	AAT	21;21;21	A;A;T	20;20;20	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1940	1942	TCA	28;28;28	T;C;A	27;27;27	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1964	1966	ATG	25;25;25	A;T;G	24;24;24	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	258	tetM	1920	1920	95.62	tetM.l15.c17.ctg.1	3086	20.8	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2354	2356	GAA	29;29;29	G;A;A	28;28;27	.	Tetracycline resistance
